Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Idexx Laboratories, Inc shares valued at $144,630 were sold by Vandebroek Sophie V. on Nov 27 ’24. At $420.44 per share, Vandebroek Sophie V. sold 344 shares. The insider’s holdings dropped to 905 shares worth approximately $0.37 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Vandebroek Sophie V. purchased 344 shares, netting a total of over 144,630 in proceeds.
Before that, SZOSTAK M ANNE had sold 500 shares from its account. In a trade valued at $234,686, the Director traded Idexx Laboratories, Inc shares for $469.37 each. Upon closing the transaction, the insider’s holdings decreased to 500 shares, worth approximately $0.0.
As published in their initiating research note from Leerink Partners on December 02, 2024, Idexx Laboratories, Inc [IDXX] has been an Outperform and the price target has been revised to $500. Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in late July. As of January 30, 2024, Piper Sandler has decreased its “an Overweight” rating to a “Neutral” for IDXX. Earlier on December 07, 2023, Exane BNP Paribas initiated its rating. Their recommendation was “an Outperform” for IDXX stock.
Analyzing IDXX Stock Performance
During the last five days, there has been a drop of approximately -6.02%. Over the course of the year, Idexx Laboratories, Inc shares have dropped approximately -26.00%. Shares of the company reached a 52-week high of $583.39 on 03/01/24 and a 52-week low of $398.50 on 11/21/24. A 50-day SMA is recorded $437.51, while a 200-day SMA reached $483.32. Nevertheless, trading volume fell to 0.54 million shares from 0.6 million shares the previous day.
Support And Resistance Levels for Idexx Laboratories, Inc (IDXX)
According to the 24-hour chart, there is a support level at 405.13, which, if violated, would cause prices to drop to 399.51. In the upper region, resistance lies at 421.76. The next price resistance is at 432.77. RSI (Relative Strength Index) is 36.43 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -9.54, which suggests the price will decrease in the coming days. Percent R is at 99.42%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
